BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 28970296)

  • 1. Diagnostic accuracy of fungal PCR and β-d-glucan for detection of candidaemia: a preliminary evaluation.
    McKeating C; White PL; Posso R; Palmer M; Johnson E; McMullan R
    J Clin Pathol; 2018 May; 71(5):420-424. PubMed ID: 28970296
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative sensitivity of 1,3 beta-D-glucan for common causes of candidaemia in South Africa.
    Chibabhai V; Fadana V; Bosman N; Nana T
    Mycoses; 2019 Nov; 62(11):1023-1028. PubMed ID: 31393662
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Value of (1-3)-β-d-glucan, Candida mannan and Candida DNA detection in the diagnosis of candidaemia.
    Mokaddas E; Khan ZU; Ahmad S; Nampoory MR; Burhamah M
    Clin Microbiol Infect; 2011 Oct; 17(10):1549-53. PubMed ID: 21883664
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Performance of Candida real-time polymerase chain reaction, β-D-glucan assay, and blood cultures in the diagnosis of invasive candidiasis.
    Nguyen MH; Wissel MC; Shields RK; Salomoni MA; Hao B; Press EG; Shields RM; Cheng S; Mitsani D; Vadnerkar A; Silveira FP; Kleiboeker SB; Clancy CJ
    Clin Infect Dis; 2012 May; 54(9):1240-8. PubMed ID: 22431804
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lower sensitivity of serum (1,3)-β-d-glucan for the diagnosis of candidaemia due to Candida parapsilosis.
    Mikulska M; Giacobbe DR; Furfaro E; Mesini A; Marchese A; Del Bono V; Viscoli C
    Clin Microbiol Infect; 2016 Jul; 22(7):646.e5-8. PubMed ID: 27256062
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative evaluation of (1, 3)-beta-D-glucan, mannan and anti-mannan antibodies, and Candida species-specific snPCR in patients with candidemia.
    Alam FF; Mustafa AS; Khan ZU
    BMC Infect Dis; 2007 Sep; 7():103. PubMed ID: 17784947
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lower (1,3)-beta-d-glucan sensitivity and in vitro levels in Candida auris and Candida parapsilosis strains.
    Mikulska M; Ullah N; Magnasco L; Codda G; Bartalucci C; Miletich F; Sepulcri C; Willison E; Vena A; Giacobbe DR; di Pilato V; Robba C; Ball L; Marchese A; Bassetti M
    Clin Microbiol Infect; 2024 Jun; 30(6):822-827. PubMed ID: 38431255
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Presence of Candida cell wall derived polysaccharides in the sera of intensive care unit patients: relation with candidaemia and Candida colonisation.
    Poissy J; Sendid B; Damiens S; Ichi Ishibashi K; François N; Kauv M; Favory R; Mathieu D; Poulain D
    Crit Care; 2014 Jun; 18(3):R135. PubMed ID: 24975380
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative Analysis of the Wako β-Glucan Test and the Fungitell Assay for Diagnosis of Candidemia and Pneumocystis jirovecii Pneumonia.
    Friedrich R; Rappold E; Bogdan C; Held J
    J Clin Microbiol; 2018 Sep; 56(9):. PubMed ID: 29899003
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Candida biomarkers in patients with candidaemia and bacteraemia.
    Martínez-Jiménez MC; Muñoz P; Valerio M; Alonso R; Martos C; Guinea J; Bouza E
    J Antimicrob Chemother; 2015 Aug; 70(8):2354-61. PubMed ID: 25900160
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of (1->3)-β-D-glucan, mannan/anti-mannan antibodies, and Cand-Tec Candida antigen as serum biomarkers for candidemia.
    Held J; Kohlberger I; Rappold E; Busse Grawitz A; Häcker G
    J Clin Microbiol; 2013 Apr; 51(4):1158-64. PubMed ID: 23363830
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined use of serum (1,3)-β-D-glucan and procalcitonin for the early differential diagnosis between candidaemia and bacteraemia in intensive care units.
    Giacobbe DR; Mikulska M; Tumbarello M; Furfaro E; Spadaro M; Losito AR; Mesini A; De Pascale G; Marchese A; Bruzzone M; Pelosi P; Mussap M; Molin A; Antonelli M; Posteraro B; Sanguinetti M; Viscoli C; Del Bono V;
    Crit Care; 2017 Jul; 21(1):176. PubMed ID: 28693606
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lower beta-1,3-D-glucan testing cut-offs increase sensitivity for non-albicans Candida species bloodstream infections.
    Forster J; Dichtl K; Wagener J
    Mycoses; 2022 May; 65(5):500-507. PubMed ID: 35020235
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of β-D-Glucan levels between Candida auris and other Candida species at the time of candidaemia: a retrospective study.
    Farooqi J; Niamatullah H; Irfan S; Zafar A; Malik F; Jabeen K
    Clin Microbiol Infect; 2021 Oct; 27(10):1519.e1-1519.e5. PubMed ID: 34111581
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Automation of serum (1→3)-beta-D-glucan testing allows reliable and rapid discrimination of patients with and without candidemia.
    Prüller F; Wagner J; Raggam RB; Hoenigl M; Kessler HH; Truschnig-Wilders M; Krause R
    Med Mycol; 2014 Jul; 52(5):455-61. PubMed ID: 24906361
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Levels of (1→3)-β-D-glucan, Candida mannan and Candida DNA in serum samples of pediatric cancer patients colonized with Candida species.
    Mokaddas E; Burhamah MH; Khan ZU; Ahmad S
    BMC Infect Dis; 2010 Oct; 10():292. PubMed ID: 20923575
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic performance of 1→3-β-d-glucan in neonatal and pediatric patients with Candidemia.
    Montagna MT; Coretti C; Lovero G; De Giglio O; Montagna O; Laforgia N; Santoro N; Caggiano G
    Int J Mol Sci; 2011; 12(9):5871-7. PubMed ID: 22016633
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Initial serum (1,3)-β-D-glucan as a predictor of mortality in proven candidaemia: findings from a retrospective study in two teaching hospitals in Italy and Brazil.
    Giacobbe DR; Esteves P; Bruzzi P; Mikulska M; Furfaro E; Mesini A; Tatarelli P; Grignolo S; Viscoli C; Colombo AL; Del Bono V
    Clin Microbiol Infect; 2015 Oct; 21(10):954.e9-17. PubMed ID: 26070961
    [TBL] [Abstract][Full Text] [Related]  

  • 19. (1,3)-β-D-glucan-based diagnosis of invasive Candida infection versus culture-based diagnosis in patients with sepsis and with an increased risk of invasive Candida infection (CandiSep): study protocol for a randomized controlled trial.
    Bloos F; Held J; Schlattmann P; Brillinger N; Kurzai O; Cornely OA; Thomas-Rüddel D
    Trials; 2018 Sep; 19(1):472. PubMed ID: 30180873
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serological biomarkers of candidemia: a retrospective evaluation of three assays.
    Dichtl K; Seybold U; Wagener J
    Infection; 2019 Apr; 47(2):217-224. PubMed ID: 30264200
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.